Diminished expression of CD40 ligand may contribute to the defective humoral immunity in patients with MHC class II deficiency

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 589-598

  Nonoyama, Shigeaki ^a,f,g   Etzioni, Amos ^c   Toru, Hano ^e   Ruggerie, Dennis P ^d   Lewis, David ^a   Pollack, Shimon ^c   Aruffo, Alejandro ^b,e   Yata, Jun Ichi ^f   Ochs, Hans D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c RAMBAM MEDICAL CENTER   (Israel)

^d Bristol Myers Squibb P ^*  (United States)

^e BRISTOL MYERS SQUIBB   (United States)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

B cell; CD40 ligand; Helper function; Immunodeficiency; MHC class II; T cell

Indexed keywords

CD69 ANTIGEN; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN E; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; PHYTOHEMAGGLUTININ;

ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; BACTERIOPHAGE PHI X 174; CASE REPORT; CELLULAR IMMUNITY; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMORAL IMMUNE DEFICIENCY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INFANT; LYMPHOCYTE PROLIFERATION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIBODIES, VIRAL; ANTIGENS, CD40; BACTERIOPHAGE PHI X 174; CD40 LIGAND; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOGLOBULINS; INFANT; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 0031933630     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<589::AID-IMMU589>3.0.CO;2-J     Document Type: Article

References (40)

1. Griscelli, C., Lisowska-Grospierre, B. and Mach, B., Combined immunodeficiency with defective expression in MHC class II genes. Immunodeficiency Rev. 1989. 1: 135-153.
2. Klein, C., Lisowska-Grospierre, B., LeDeist, F., Fischer, A. and Griscelli, C., Major histocompatibility complex class II deficiency: Clinical manifestations, immunologie features, and outcome. J. Pediatr. 1993. 123: 921-928.
3. Clement, L., Plaeger-Marshall, S., Haas, A., Saxon, A. and Martin, A. M., Bare lymphocyte syndrome. Consequences of absent class II major histocompatibility antigen expression for B lymphocyte differentiation and function. J. Clin. Invest. 1988. 81: 669-675.
4. Cresswell, P., Assembly, transport and function of MHC class II molecules. Annu. Rev. Immunol. 1994. 12: 259-293.
5. Cosgrove, D., Gray, D., Dierich, A., Kaufman, J., Lemeur, M., Benoist, C. and Mathis, D., Mice lacking MHC class II molecules. Cell 1991. 66: 1051-1066.
6. + cells in the human neonate. J. Immunol. 1990. 145: 102-108.
7. Nabavi, N., Freeman, G. J., Gault, A., Godfrey, D., Nadler, L. M. and Glimcher, L. H., Signaling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature 1992. 360: 266-268.
8. Morio, T., Geha, R. S. and Chatila, T. A., Engagement of MHC class II molecules by staphylococcal superantigen activates src-type protein tyrosine kinases. Eur. J. Immunol. 1994. 24: 651-658.
9. Hollenbaugh, D., Ochs, H. D., Noelle, R. J., Ledbetter, J. A. and Aruffo, A., The role of CD40 ligand in the regulation of the immune response. Immunol. Rev. 1994. 138: 23-37.
10. Nonoyama, S., Hollenbaugh, D., Aruffo, A., Ledbetter, J. A. and Ochs, H. D., B cell activation via CD40 is required for specific Ab production by Ag stimulated human B cells. J. Exp. Med. 1993. 178: 1097-1102.
11. Nonoyama, S., Farrington, M. L. and Ochs, H. D., Effect of IL-2 on immunoglobulin production by anti-CD40 activated human B cells: synergistic effect with IL-10 and antagonistic effect with IL-4. Clin. Immunol. Immunopathol. 1994. 72: 373-379.
12. Jabara, H. H., Fu, S. M., Geha, R. S. and Vercelli, D., CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 1990. 172: 1861-1864.
13. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousset, F. and Banchereau, J., Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 1992. 175: 671-682.
14. Nonoyama, S., Penix, L. A., Edwards, C. P., Lewis, D. B., Ito, S., Aruffo, A., Wilson, C. B. and Ochs, H. D., Diminished expression of CD40 ligand by activated neonatal T cells. J. Clin. Invest. 1995. 95: 66-75.
15. Villard, J., Lisowska-Grospierre, B., van den Elsen, P., Fischer, A., Reuth, W. and Mach, B., Mutation of RFXAR, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 1997. 337: 748-753.
16. Grusby, M. J. and Glimcher L. H., Immune responses in MHC class II-deficient mice. Annu. Rev. Immunol. 1995. 13: 417-435.
17. Mach, B., Steimle, V. and Reith, W., MHC class II-deficient combined immunodeficiency: A disease of gene regulation. Immunol. Rev. 1994. 138: 207-221.
18. Marshall, L. S., Aruffo, A., Ledbetter, J. A. and Noell, R. J., The molecular basis for T cell help in humoral immunity: CD40 and its ligand, gp39. J. Clin. Immunol. 1993. 13: 165-174.
19. Grewal, I. S., Xu, J. and Flavell, R. A., Impairment of antigen-specific T-cell priming in mice-lacking CD40 ligand. Nature 1995. 378: 617-620.
20. van Essen, D., Kikutani, H. and Gray, D., CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 1995. 378: 620-623.
21. Wolf, H. M., Hauber, I., Gulle, H., Thon, V., Eggenbauer, H., Fischer, M. B., Fiala, S. and Eibl, M. M., Twin boys with major histocompatibility complex class II deficiency but inducible immune responses. N. Engl. J. Med. 1995. 332: 86-90.
22. + helper T cells in class II major histocompatibility complex mutant mice. J. Exp. Med. 1994. 179: 1997-2004.
23. Durandy, A., de Saint Basile, G., Lisowska-Grospierre, B., Gauchat, J.-F., Forveille, M., Kroczek, R. A. and Bonnefoy, J.-Y., Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J. Immunol. 1995. 154: 1560-1568.
24. Brugnoni, D., Airo, P., Graf, D., Marconi, M., Molinari, C., Braga, D., Malacarne, F., Soresina, A., Ugazio, A. G., Cattaneo, R., Kroczek, R. A. and Notarangelo, L. D., Ontogeny of CD40 expression by activated peripheral blood lymphocytes in humans. Immunol. Lett. 1996. 49: 27-30.
25. Brugnoni, D., Airo, P., Graf, D., Marconi, M., Lebowitz, M., Plebani, A., Gilliani, S., Malacarne, F., Cattaneo, R., Ugazio, A. G., Albertini, A., Kroczek, R. A. and Notarangelo, L. D., Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur. J. Immunol. 1994. 24: 1919-1924.
26. Ochs, H. D., Slichter, S. J., Harker, L. A., von Behrens, W. E., Clark, R. A. and Wedgwood, R. J., The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes, and platelets. Blood 1980. 55: 243-252.
27. Ochs, H. D., Buckley, R. H., Kobayashi, R. H., Kobayashi, A. L., Sorensen, R. U., Douglas, S. D., Hamilton, B. L. and Hershfield, M. S., Antibody responses to bacteriophage Φ × 174 in patients with adenosine deaminase deficiency. Blood 1992. 80: 1163-1171.
28. Bernstein, L. J., Ochs, H. D., Wedgwood, R. J. and Rubinstein, A., Defective humoral immunity in pediatric acquired immune deficiency syndrome. J. Pediatr. 1985. 107: 352-357.
29. Tony, H. P. and Parker, D. C., Major histocompatibility complex-restricted, polyclonal B cell responses resulting from helper T cell recognition of anti-immunoglobulin presented by small B lymphocytes. J. Exp. Med. 1985. 161: 223-241.
30. Ranheim, E. A. and Kipps, T. J., Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 1993. 177: 925-935.
31. Poudrier, J. and Owens, T., CD54/intracellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation. J. Exp. Med. 1994. 179: 1417-1427.
32. Markowitz, J. S., Rogers, P. R., Grusby, M. J., Parker, D. C. and Glimcher, L. H., B lymphocyte development and activation independent of MHC class II expression. J. Immunol. 1993. 150: 1223-1233.
33. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L. S., Stenkamp, R., Neubauer, M., Roberts, R. L., Noelle, R. J., Ledbetter, J. A., Fracke, U. and Ochs, H. D., The CD40 ligand, gp39, is defective in activated T cells from patients with x-linked hyper-IgM syndrome. Cell 1993. 72: 291-300.
34. Rijkers, G. T., Roord, J. J., Koning, F., Kuis, W. and Zegers, B. J. M., Phenotypical and functional analysis of B lymphocytes of two siblings with combined immunodeficiency and defective expression of major histocompatibility complex (MHC) class II antigens on mononuclear cells. J. Clin. Immunol. 1987. 7: 98-106.
35. Steimle, V., Otten, L. A., Zufferey, M. and Mach, B., Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 1993. 75: 135-146.
36. Hollenbaugh, D., Grosmaire, L. S., Kullas, C. D., Chalupny, N. J., Braesch-Andersen, S., Noelle, R. J., Stamenkovic, I., Ledbetter, J. A. and Aruffo, A., The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 1992. 11: 4313-4321.
37. Nonoyama, S., Farrington, M. L., Ishida, H., Howard, M. and Ochs, H. D., Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J. Clin. Invest. 1993. 92: 1282-1287.
38. Ochs, H. D., Davis, S. D. and Wedgwood, R, J., Immunologic responses to bacteriophage Φ × 174 in immunodeficiency diseases. J. Clin. Invest. 1971. 50: 2559-2568.
39. Grubb, R. and Swahn, B., Destruction of some agglutinins but not of others by two sulfhydryl compounds. Acta. Pathol. Microbiol. Scand. 1958. 43: 305-309.
40. Conley, M. E. and Stiehm, E. R., Immunodeficiency disorders: General consideration. In Stiehm, E. R. (Ed.) Immunologic Disorders in Infants and Children. W. B. Saunders, Philadelphia 1996, pp. 201-202.